Perficient: Drug Development

SEPTEMBER 26, 2023

We’re excited to introduce you to two illuminating articles recently featured on CMSWire.com, “The Heart of Composable Architecture,” and “Navigating the Long Tail of Composable in the Martech Landscape” Both articles were penned by Perficient’s own David San Filippo, Sitecore Principal and Sitecore Technology MVP.

Marketing 110

Marketing Production 110

Broad Institute

DECEMBER 18, 2023

Brain disorders are difficult to study and many drug candidates have failed in clinical trials, causing pharmaceutical companies to reduce their investments or even exit the field entirely. So the need and the markets are there. Your review article discussed the need to study genetically diverse patient samples.

Drug Development 130

Drug Development Clinical Trials Drugs Disease 130

Perficient: Drug Development

SEPTEMBER 17, 2024

This year, I’m particularly excited about how far we’ve advanced with Optimizely One in collaboration with Perficient, which is described as an operating system for marketing teams. Many organizations are shifting away from piecing together various products to build their marketing technology systems. Will you be at Opticon 2024?

Marketing 109

Marketing Production Government 109

Drug Patent Watch

DECEMBER 17, 2024

Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. Today, they’re strategic partners in drug development and manufacturing, offering end-to-end solutions that can make or break a pharmaceutical company’s success.

Pharmaceuticals 90

Pharmaceuticals Therapies Production Pharmaceutical Companies 90

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. Cavlan explains that “they are brilliant at developing and bringing new drugs to market.”

Drug Development 98

Drug Development Drugs Clinical Development Pharmaceutical Companies 98

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. This boosts the inventors reputation, making it easier to secure funding for development and commercialisation.

Engineering 105

Engineering International Drug Development Science 105

Drug Target Review

APRIL 7, 2025

In a recent survey conducted by ICON, Plc, biomarker selection was identified by 35 percent of respondents as a top challenge among drug developers for phase I trials, second only to navigating regulatory compliance (- 38 percent). Silver Spring (MD): Food and Drug Administration (US); 2016-. 113:9861002.

Clinical Development 59

Clinical Development Clinical Trials Clinical Pharmacology Trials 59

Drug Patent Watch

FEBRUARY 26, 2025

In this article, we'll delve into the world of drafting drug patent applications for biologic drugs. To draft a strong patent application, you need to understand the nuances of biologic drug development, including the production process, stability, and formulation. Read the full article here: [link]

Drugs 59

Drugs Government Regulations Compliance 59

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. EU, and other regions.

Drug Development 52

Drug Development Compliance Drugs Regulations 52

Drug Patent Watch

DECEMBER 12, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and manufacturing. With the increasing complexity of drug development and the need for efficient, cost-effective solutions, selecting the right CDMO is crucial.

Drug Development 98

Drug Development Production Clinical Trials Pharmaceutical Companies 98

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Drugs 52

Drug Target Review

JANUARY 14, 2025

In the next article, we will discuss the tools scientists can use to execute the workflow described in Figure 1. Figure 1: High-level workflow for early drug discovery. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

Drugs 69

Drugs Protein Expression Science Research 69

Drug Target Review

DECEMBER 6, 2024

In drug discovery and biological research, the scientists workflow often follows a structured and iterative approach to ensure accuracy, reproducibility and scientific integrity. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics.

RNA 52

RNA Drugs Research Science 52

Perficient: Drug Development

SEPTEMBER 26, 2023

If there’s one thing healthcare marketers need more of, it’s time. Your day is most likely taken up with monitoring campaigns, analyzing metrics of your digital marketing, adjusting strategies and, of course, meetings. You do want to provide context for the topics you discuss in articles. But you don’t want to be too clinical.

Marketing 52

Marketing Engineering Doctors Research 52

Alta Sciences

MARCH 4, 2025

Over time, this group of professionals evolved and grew, having regular stakeholder interactions with the FDA and Controlled Substances staff to discuss requirements for drug developers. I have spent the better part of my career working to make drugs safer. About the Author Beatrice Setnik, PhD, Chief Scientific Officer.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

Perficient: Drug Development

OCTOBER 18, 2023

In the fast-paced world of digital marketing, staying ahead of the curve is crucial for success. We highly recommend giving this article a thorough read. It’s not just a guide—it’s a roadmap to unlocking the full potential of personalization in your digital marketing endeavors.

Marketing 52

Marketing 52

Perficient: Drug Development

MARCH 5, 2024

Depending on the size of your marketing team, one high-quality blog article a week could be a big ask. We’ve pulled together seven strategies for how to stock your editorial calendar with the kinds of relevant article topics your healthcare organization’s consumers are asking for.

Marketing 52

Marketing Research 52

Perficient: Drug Development

DECEMBER 12, 2024

Social media is a pivotal component of any marketing strategy in today’s digital era. Salesforce Marketing Cloud Social Studio offers a comprehensive platform for managing, scheduling, creating, and monitoring social media posts. What is Salesforce Marketing Cloud Social Studio?

Marketing 52

Marketing 52

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. All types of activities encouraging women in STEM is important, like this article.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

Perficient: Drug Development

SEPTEMBER 3, 2024

The world of Digital Marketing is challenging and always updating with new strategies. Gen AI can pump up your digital marketing efforts by creating highly engaged SEO-friendly content and boost your brand on SERP (Search Engine Result Page). What is Generative AI, and How Does it Work?

Marketing 52

Marketing Production Engineering Research 52

Perficient: Drug Development

OCTOBER 8, 2024

One shining example is our recruitment strategy for Bayhealth, which was recently featured by the online publication, Strategic Health Care Marketing. Recognizing the need for a unified front, our team emphasized the importance of collaboration between HR and marketing.

Marketing 52

Marketing Testimonials Hospitals Science 52

Perficient: Drug Development

NOVEMBER 13, 2023

What You’ll Learn from the Piece This article discusses the concept of unified commerce and how it goes beyond omnichannel retail by connecting and synchronizing all channels, systems, and processes, both front-end and back-end, to deliver a consistent shopping experience.

Marketing 52

Marketing 52

Drug Target Review

JULY 4, 2023

In this article, Petra Dieterich, Ian Glassford, and Jeff Mocny, Scientific Leaders at Abzena discuss real-world data that is challenging traditional scientific thinking on the ADC therapeutic window. The global ADC market is expected to continue this steep upward trajectory and is anticipated to exceed $16 Billion by 2026.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

Alta Sciences

NOVEMBER 15, 2024

4 Essential Topics to Cover in Your First CRO Meeting pmjackson Fri, 11/15/2024 - 19:22 Starting a partnership with a contract research organization (CRO) is a sometimes intimidating—yet exciting—first step in your drug development journey. It’s equally important to communicate your long-term plans.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

The Pharma Data

NOVEMBER 24, 2020

Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible. Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you.

FDA 52

FDA Drug Development Compliance Drugs 52

Agency IQ

JUNE 9, 2023

What will the orphan drug market exclusivity haircut mean for industry? Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. Orphan designation in the E.U.

Marketing 40

Marketing Regulations Biosimilars Drugs 40

Drug Target Review

APRIL 7, 2025

GPCRs are critical targets for drug development due to their involvement in numerous disease pathologies, with many medications working by either activating or inhibiting these receptors. 2022) Why 90% of clinical drug development fails and how to improve it?, References Sun D, et al. doi:10.1016/j.apsb.2022.02.002.

Fragment Screening 52

Fragment Screening Drugs Small Molecule Biophysical Assays 52

Perficient: Drug Development

MARCH 5, 2024

As the new year has begun, the Digital Marketing team at Perficient has identified a number of areas where they expect a continued focus throughout 2024 within their areas of expertise. Learn more about what’s top of mind for experts in Content, Audience Insights, SEO, Paid Media and Digital Marketing Strategy below.

Marketing 52

Marketing Engineering Production Research 52

Perficient: Drug Development

NOVEMBER 22, 2023

People love superlatives In an HCIC keynote session, John Youshaei, Forbes writer and former marketing lead at YouTube and Instagram, explored core principles of writing for a consumer audience, especially on social channels. So, without further adieu, here are our top insights from HCIC 2023. 1.

Marketing 52

Marketing International Regulations Government 52

Perficient: Drug Development

MARCH 12, 2024

You can watch the whole discussion here: The rest of this article was generated by AI based on the discussion in the Video The Journey to Healthcare Excellence with Sitecore The healthcare industry stands at the forefront of technological transformation, aiming to deliver personalized, efficient, and comprehensive care to patients.

Marketing 52

Marketing Compliance Engineering 52

Perficient: Drug Development

AUGUST 19, 2024

I have even heard the phrase “Please check the report, I don’t understand the models and hence trust the number” So, in the risk function, while this is a race for data aggregation, structured data, unstructured data, data quality, data granularity, news feeds, market overviews, its also a challenge from an acceptance perspective.

Regulations 109

Regulations Marketing Government Compliance 109

Perficient: Drug Development

AUGUST 28, 2024

With that backdrop, we – the authors of this article – would like to introduce ourselves and share how our leadership in Perficient’s ERGs has affected our experience. We met in May 2023 developing an internal Pride Month virtual event on queer history and raised over $1300 for various LGBTQ+ charities.

Marketing 104

Marketing International 104

KIF1A

JUNE 3, 2023

In this week’s article, researchers in Japan investigated the genetics of hereditary spastic paraplegia in a retrospective study : this means they went back and analyzed existing data, in this case the genetics and clinical profiles of 37 children diagnosed with HSP.

FDA 98

FDA Trials FDA Approval Disease 98

Drug Target Review

MARCH 15, 2024

Advancements in cell line development (CLD), including screening and selection of final clones, scale up, automation and digitalisation have enabled precision and enhanced productivity. This article will focus on a novel transposon system for stable clone development with low variation.

Engineering 105

Engineering Molecular Biology Protein Expression Medical Schools 105

Perficient: Drug Development

DECEMBER 26, 2023

Zippia released some market numbers for the entertainment industries this year, that include a $717 billion dollar U.S. market size (6.9% Though I’m keen to agree with the Big Think article that, instead, science-fiction inspires the people who shape the future. Even 6,000 years ago, storytellers were highly regarded in society.

Production 116

Production Science Marketing 116

FDA Law Blog: Biosimilars

SEPTEMBER 18, 2024

That clause excludes those ingredients that were first marketed as drug ingredients. The phrase in subsection (ii) “authorized for investigation as a new drug” is generally accepted to mean that an IND is in effect.

Production 59

Production FDA Licensing Licensing 59

Vial

MAY 20, 2024

Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. The two broadest categories of drug development can be separated into the preclinical and clinical research stages. over this period.

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52